This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Watson JD, Crick FHC. (1953) A structure for deoxyribose nucleic acid. Nature 171: 737, 738.
Neuhausen S. (1999) Ethnic differences in cancer risk resulting from genetic variation. Cancer 86 (8): 1755–1762.
Webb MJ. (1998) Symposium: genetic testing and management of the cancer patient and cancer families. J Am Coll Surg 187(41):449–456.
Weitzel JN. (1999) Genetic cancer risk assessment. Cancer 86 (8): 1663–1672.
Lynch HT, et al. (1999) Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Cancer 86 (8): 1629–1636.
Gelehrter TD, et al. (1998) Principles of Medical Genetics. Baltimore, MD: Williams and Wilkins.
Heppner C, Reincke M, Agarwalsk, et al. (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms. J Clin Endo Meta 84(11):216–219.
Knudson AG. (1996) Hereditary cancer:Two hits revisited. J CancerRes Clin Oncol 122 (3): 135–140.
Leach FS, Nicolaides NC, Papadopoulos N, et al. (1993) Mutation of a MutS homologue in hereditary non-polyposis colorectal cancer. Cel175:1215–1225.
Nystrrom-Lahti M, Parson R, Sistonen P, et al. (1994) Mismatch repair genes on chromosome 2p and 3p account for a major share of hereditary non-polyposis colorectal cancer families evaluated by linkage. Am J Hum Genet 55: 659–665.
Rebbeck TR. (1999) Inherited genetic predisposition in breast cancer-a population-based perspective. Cancer 86 (8): 1673–1681.
Gauthier-Villars M, et al. (1999) Genetic testing for breast cancer predisposition. Breast Cancer Manag 79(5):1 171–1 187.
Gayther SA, et al. (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for genotype-phenotype correlation. Nat Genet 11: 428–433.
Hughes KS, et al. (1999) Prophylactic mastectomy and inherited predisposition to breast carcinoma. Cancer 86 (8): 1682–1696.
Berchuck A, et al. (1999) Managing hereditary ovarian cancer risk. Cancer 86 (8): 1697–1704.
Petersen GM, et al. (1999) Genetic testing and counseling for hereditary forms of colorectal cancer. Cancer 86 (8): 1720–1730.
Powell SM, et al. (1993) Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329: 1982–1987.
Green MH. (1999) The genetics of hereditary melanoma and nevi. Cancer 86 (8): 1644–1657.
Cannon-Albright IA, et al. (1994) Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S726 and D9S 171. Genomics 23: 265–268.
Cannon-Albright IA, et al. (1994) Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 54: 6041–6044.
Kamb GA, et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436–440.
Wolfel HT, et al. (1995) A pl 6INK4a in sensitive CDK4 mutant targeted by cytotoxic T-cells in a human melanoma. Science 269: 1281–1284.
Calender A. (1998) genetic testing in multiple endocrine neoplasia and related syndromes. Forum (Genova) 8(2):146–159.
Wohllk N, et al. (1996) Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endo Metabol Clin 25 (1): 1–25.
Ilipoulos KO, et al. (1995) Tumor suppressor by the human von Hippel-Lindau gene product. Nat Med 1:822–826.
Duan, DR, et al. (1995) Inhibition of transcriptional elongation by the VHL tumor suppressor protein. Science 269: 1402–1406.
Seizinger BR, et al. (1988) von Hippel Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268,269.
Friedrich CA. (1999) von Hippel Lindau syndrome—a pleomorphic condition. Cancer 86(8):1658–1662.
Bondy M, et al. (1997) Ethical issues of genetic testing and their implications in epidemiological studies. Ann Epidemiol 7: 363–366.
Parker LS, et al. (1996) Standards of care and ethical concerns in genetic testing and screening. Clin Obstet Gynnocol 9 (4): 873–884.
White MT, et al. (1999) Genetic testing for disease susceptibility: social, ethical and legal issues for family physicians. Am Fam Physician 60 (3): 748–755.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ling, Z., Aziz, K., Wu, G.Y. (2002). Molecular Genetics and Cancer Screening. In: Aziz, K., Wu, G.Y. (eds) Cancer Screening. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-191-6_18
Download citation
DOI: https://doi.org/10.1007/978-1-59259-191-6_18
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-229-2
Online ISBN: 978-1-59259-191-6
eBook Packages: Springer Book Archive